Chikungunya: Symptoms, Causes, Treatment, Joint Pain & Prevention

Every monsoon season at Felix Hospital, Sector 137, Noida, the same pattern unfolds. A patient walks in  sometimes barely able to grip the counter  describing a fever that broke three days ago but joint pain so severe that climbing out of bed has become a daily ordeal. Their knuckles are swollen. Their ankles ache. They assumed they would be fine once the fever left. Nobody told them the worst part of chikungunya often begins after the fever ends.

Chikungunya is not simply a mosquito-borne fever. It is a viral disease whose defining feature  crippling joint pain  can outlast the acute illness by months or, in a significant number of patients, by years. Up to 60% of patients develop persistent, disabling joint pain that lasts for months to years. Although chikungunya has a low fatality rate, periodic epidemics impose a substantial socioeconomic burden driven by workforce loss, increased pressure on healthcare systems, and chronic sequelae.

For residents of Noida, Greater Noida, and the Delhi NCR  where the Aedes mosquito thrives during and after the monsoon, understanding chikungunya in full is not academic. It is practical, seasonal, and urgent.

What is Chikungunya?

Chikungunya is a viral disease spread by mosquito bites, primarily from Aedes aegypti and Aedes albopictus mosquitoes, which mainly bite during daylight hours. It causes fever and severe joint pain. Other symptoms include muscle pain, rash, headache, and severe fatigue. While most people recover after a week, joint pain can sometimes last for much longer.

The name "chikungunya" comes from a Makonde word meaning "that which bends up"  describing the stooped, contorted posture adopted by patients in agony from joint inflammation. It is an apt description. When chikungunya joint pain is at its worst, patients cannot straighten their fingers, walk without limping, or perform basic daily activities.

The chikungunya virus was first isolated and identified in Tanzania in 1952. Over the last two decades, it has again become a key pathogen threatening global public health. Infection can cause acute febrile illness, with typical clinical features including high fever, severe polyarthritis, and rash.

The chikungunya virus underwent an unprecedented resurgence from 2024 to 2025. In India, where both Aedes aegypti and Aedes albopictus are endemic, chikungunya outbreaks occur seasonally  with the post-monsoon period presenting the highest transmission risk across the NCR.

How Does Chikungunya Spread?

The chikungunya virus is transmitted by the Aedes mosquito. It is common in Africa, India, Pakistan, Nepal, Southeast Asia, China, the Caribbean, South and Central America, and limited areas of Europe.

The Aedes aegypti and Aedes albopictus mosquitoes are the primary vectors. What makes these mosquitoes particularly challenging from a public health perspective is their behaviour unlike the Anopheles mosquito that transmits malaria and bites at night, Aedes mosquitoes bite during daylight hours, particularly in the early morning and late afternoon. Standard mosquito nets, which protect sleepers at night, offer no protection against Aedes daytime biting.

The transmission cycle works as follows: An Aedes mosquito bites a person infected with chikungunya virus during the viraemic phase of their illness. The virus replicates within the mosquito. When the infected mosquito bites another person, the virus is transmitted through saliva into the new host's bloodstream.

Chikungunya is not transmitted from one person to another directly. You cannot contract chikungunya through touch, coughing, sneezing, or sharing food or water with an infected person. The mosquito is the essential intermediary.

Why Noida and Greater Noida are high-risk areas: The monsoon and post-monsoon months July through October  create ideal breeding conditions for Aedes mosquitoes across the NCR. Waterlogged construction sites, uncovered water containers, discarded tyres, flower pots, and clogged drains all serve as breeding grounds within metres of homes and offices.

Key Symptoms of Chikungunya: Early Signs to Identify

Symptoms of chikungunya typically appear 4 to 8 days after being bitten by an infected mosquito.

Understanding the symptom timeline helps patients recognise what they are dealing with  and avoid the common mistake of assuming recovery is complete when the fever breaks.

Acute Phase Symptoms (Days 1–7)

Sudden High Fever Chikungunya announces itself abruptly. Temperature typically spikes to 39–40°C within hours, often accompanied by shaking chills. This sudden onset  without the gradual build-up of a standard viral fever  is clinically characteristic.

Severe Joint Pain (Polyarthralgia) The most common symptom is an abrupt onset of fever, often accompanied by joint pain described as excruciating. The pain affects multiple joints simultaneously  characteristically the small joints of the hands, wrists, ankles, and feet. It is typically bilateral and symmetrical  both hands, both ankles  distinguishing it from the predominantly unilateral joint pain of other conditions.

Skin Rash A maculopapular rash with flat and raised red spots  typically appears on the trunk, arms, legs, and face, often accompanied by itching on the palms, soles, or all over the body. The rash usually appears between days 2 and 5 of illness and resolves within a few days.

Muscle Pain (Myalgia) Deep muscle aching particularly in the back, shoulders, and legs  is reported by most patients alongside the joint pain.

Headache A frontal headache is common during the febrile phase, often described as persistent and moderate to severe.

Fatigue Fatigue or general weakness is a prominent symptom. The profound tiredness of acute chikungunya is disproportionate to the length of illness  many patients describe being unable to function for the first week.

Additional symptoms include swelling in the face, hands, and feet; headache or pain behind the eyes; swollen lymph nodes; abdominal pain, diarrhoea, or vomiting; and red, watery eyes.

The Post-Acute Phase When the Fever Goes But the Pain Stays

This is the stage that most patients are not warned about. The fever resolves in most patients within 5 to 7 days. But the joint pain frequently does not follow it out the door.

Many patients recover within several weeks, but up to 50% develop chronic joint pain and swelling for more than 12 weeks  referred to as chronic chikungunya arthritis (CCA).

For many patients across Noida and Greater Noida, this chronic phase, not the acute fever, is what brings them to Felix Hospital's rheumatology and internal medicine departments.

Chikungunya vs. Dengue vs. Zika: How to Tell the Difference

During the monsoon season in the NCR, three mosquito-borne viral illnesses  chikungunya, dengue, and Zika  can present with overlapping symptoms. Getting the diagnosis right matters because dengue can become a platelet-dropping emergency requiring specific hospital management, while chikungunya is managed primarily for joint symptoms.

Chikungunya virus RNA testing is recommended within the first 8 days of infection. Dengue and Zika viruses are transmitted by the same mosquitoes, causing infections with clinical features similar to chikungunya, and should be considered in the diagnostic evaluation. It is important to exclude dengue virus infection, because proper clinical management of dengue can improve outcome.

In chikungunya, lymphocytes are often reduced (lymphopenia), whereas dengue usually causes a decrease in neutrophils and platelets. This CBC pattern is a useful early differentiating marker when both conditions are clinically possible.

The practical takeaway for patients in Noida: Any fever with severe joint pain during monsoon season should be tested for both chikungunya and dengue simultaneously. At Felix Hospital, our in-house pathology lab can run both panels from a single blood sample, with same-day results.

Understanding Chikungunya Joint Pain (Arthralgia) and Recovery Timeline

The joint pain of chikungunya is not a side effect, it is the central feature of the disease, and it deserves detailed explanation because it is so commonly underestimated and so poorly understood by patients.

Why Is Chikungunya Joint Pain So Severe?

Chikungunya fever, caused by the chikungunya virus, triggers both acute pain and persistent chronic pain. The mechanisms involve viral replication within joint tissues, a massive inflammatory cytokine response, and in some patients, a dysregulated immune response that does not switch off when the virus is cleared.

A recent study suggested a potential link between immune dysregulation and increased osteoclast activity, which may contribute to persistent joint pain in patients with chronic chikungunya fever. This means that in some patients, the virus triggers a chain of immune events that continue to damage joint tissue even after the virus itself is no longer detectable, similar in mechanism to autoimmune arthritis.

Chikungunya virus persists in joint-associated macrophages and promotes chronic disease. This viral persistence within joint tissue  even at very low levels  is one of the mechanisms sustaining inflammation long after the acute illness resolves.

Which Joints Are Affected?

Joint pain in chikungunya is characteristically:

• Polyarticular multiple joints at the same time

• Bilateral and symmetrical  both hands, both ankles, both wrists

• Predominantly small joints  fingers, wrists, ankles, toes  though larger joints including knees and shoulders can be involved

• Associated with morning stiffness  often worst on waking, easing with movement but returning with rest

The Recovery Timeline

The chikungunya joint pain recovery timeline differs widely across individuals.

Almost 20–40% of chikungunya patients fail to recover completely and suffer from chronic pain and arthritis as a sequel.

Risk factors for developing chronic chikungunya arthritis:

• Age above 45

• Pre-existing joint disease  osteoarthritis or rheumatoid arthritis

• High viral load during the acute phase

• Severe joint swelling during the acute illness

• Returning to full activity too quickly before inflammation has resolved

People with osteoarthritis, rheumatoid arthritis, or general age-related joint wear are more likely to experience long-term joint pain after chikungunya. Their joints are already vulnerable, and viral-induced inflammation accelerates degeneration.

Diagnosis: How is Chikungunya Diagnosed?

A clinical diagnosis  based on fever, severe bilateral joint pain, and rash in a patient from an endemic area  is often accurate. But laboratory confirmation is essential for distinguishing chikungunya from dengue, which has very different management implications.

Chikungunya virus disease can be diagnosed by nucleic acid testing during the acute phase of infection or by serologic testing after the first week of illness.

RT-PCR (Reverse Transcriptase Polymerase Chain Reaction)

The RT-PCR test is most useful during the acute phase of infection, within the first five days after symptoms begin. It is highly sensitive and specific, making it the preferred choice during the first few days of illness when the virus is actively circulating in the blood.

Serological Testing  IgM and IgG Antibodies

IgM antibodies usually appear between 5 days and several weeks after symptoms start, while IgG antibodies typically appear from two weeks onward.

The IgM test detects recent infection, while the IgG test indicates past infection or developed immunity. Molecular tests and some rapid tests may provide results within a day. Antibody testing may take a few days.

Testing window summary:

Why Dengue Must Be Excluded First

In dengue-endemic areas  which include all of Noida and Greater Noida  acetaminophen (paracetamol) is the preferred first-line treatment for fever and joint pain until dengue can be ruled out, to reduce the risk of haemorrhage. Patients with suspected chikungunya should be managed as dengue until dengue has been excluded.

At Felix Hospital, our standard protocol for any patient presenting with monsoon fever and joint pain includes simultaneous testing for both chikungunya and dengue  ensuring the right diagnosis and the right management from day one.

Treatment and Management for Chikungunya Virus

There is currently no specific antiviral drug that kills the chikungunya virus. Treatment is focused on relieving the symptoms. This is not a limitation unique to chikungunya  the same is true for most viral illnesses. The goal of treatment is to make the patient comfortable while the immune system does the work of clearing the virus, and to prevent the acute illness from progressing to chronic joint disease.

Acute Phase Management

Paracetamol  First and Only Safe Antipyretic Paracetamol is the preferred first-line treatment for fever and joint pain in dengue-endemic areas, to reduce the risk of haemorrhage until dengue can be excluded. Aspirin and ibuprofen must be avoided until dengue is ruled out  both increase bleeding risk and are contraindicated in dengue.

NSAIDs After Dengue is Excluded NSAIDs can be used to help with acute fever and pain once dengue has been excluded. Ibuprofen or naproxen, used at appropriate doses for limited periods, can provide meaningful joint pain relief in the acute and sub-acute phase.

Rest and Hydration Treatment of chikungunya disease is symptomatic and may include rest, fluids, and use of analgesics and antipyretics. Adequate hydration maintains circulation and supports immune function. ORS, coconut water, and clear soups are all appropriate.

Joint Protection During the acute phase, affected joints should be rested  not immobilised, but not overloaded. Gentle range-of-motion movements prevent stiffness from worsening while protecting inflamed joint tissue from further damage.

Chronic Chikungunya Arthritis Management

For patients who develop chronic joint pain beyond 12 weeks  a significant proportion of chikungunya patients at Felix Hospital management escalates:

For patients with persistent joint pain related to chikungunya virus disease, use of NSAIDs, corticosteroids including topical preparations, and physical therapy may help lessen the symptoms.

NSAIDs for chronic arthralgia: Regular anti-inflammatory doses of ibuprofen, naproxen, or diclofenac help control ongoing joint inflammation. Used with gastroprotective cover (a proton pump inhibitor) for prolonged courses.

Corticosteroids: Short courses of oral prednisolone are used in patients with significant joint swelling and functional impairment that does not respond to NSAIDs alone. Topical corticosteroid preparations can be applied over specific acutely inflamed joints.

Hydroxychloroquine: This antimalarial drug has been used in several Indian studies for chronic chikungunya arthritis with demonstrable benefit in reducing inflammation. At Felix Hospital, our rheumatology team assesses each patient for hydroxychloroquine suitability on an individual basis.

Physiotherapy and Rehabilitation: Physical therapy is a cornerstone of chronic chikungunya arthritis management  not an optional add-on. Targeted exercises maintain joint mobility, prevent deformity, build supporting muscle strength, and improve functional capacity.

What to Eat and Avoid During Chikungunya Recovery:

Eat:

• Papaya leaf juice  widely used in India; may support immune recovery and mild platelet support

• Turmeric milk (haldi doodh)  curcumin has evidence-backed anti-inflammatory properties relevant to joint recovery

• Omega-3 rich foods  walnuts, flaxseeds, mustard oil  reduce systemic inflammation

• Protein-rich foods  dal, eggs, chicken  support tissue repair

• Vitamin C sources  amla, citrus fruits, guava  support immune function and collagen synthesis

• Coconut water, ORS, and herbal teas  maintain hydration and electrolyte balance

Avoid:

• Spicy, oily, and heavy fried foods  tax the digestive system during illness

• Alcohol  dehydrating and immunosuppressive

• Caffeine excess  disrupts sleep, which is essential for immune recovery

• NSAIDs before dengue is excluded  always take paracetamol first

Is There a Chikungunya Vaccine? Latest Updates

This is one of the most asked questions at Felix Hospital's travel medicine and infectious disease consultations  and the answer has changed significantly in recent years.

IXCHIQ (VLA1553) is a live attenuated chikungunya vaccine approved by the US FDA in 2023 for adults aged 18 years and above. It represents a milestone in the prevention of chikungunya.

A second vaccine, using a virus-like particle but not itself a virus, has also been developed and can be used in people aged 12 years and older who are at increased risk of exposure, such as travellers to endemic areas and laboratory personnel.

Current status in India (2025–2026): The IXCHIQ vaccine is not yet widely available in routine clinical practice in India, though discussions about its regulatory pathway are ongoing. Travellers from India to regions with active chikungunya outbreaks  South America, Caribbean, parts of Africa  should discuss vaccination with a travel medicine specialist before departure.

Vaccine recipients are advised that the live attenuated vaccine virus could be detected in the blood of some individuals in the first few weeks after vaccination. The virus-like particle vaccine does not carry this concern and may be preferable in certain populations.

Important limitations of current vaccines:

• IXCHIQ is not licensed for use during pregnancy

• Not currently recommended for children under 18 (IXCHIQ)

• Not yet routinely available in Indian clinical practice

• Regardless of vaccination, personal mosquito protection remains essential

For now, across Noida and Greater Noida, prevention rests on mosquito control  not vaccination. Until the vaccine is routinely available in India, environmental and personal protection measures are the only available strategy.

Prevention and Mosquito Control Strategies

Prevention of chikungunya in the NCR requires action at both the individual and household level. The Aedes mosquito is a domestic breeder  it does not travel far from where it breeds. This means the breeding site is almost always within or immediately around the home.

Eliminate Breeding Sites  The Most Effective Prevention

Aedes mosquitoes breed in small collections of clean, stagnant water. Every container that holds water within and around the home is a potential breeding site:

• Flower pots and plant saucers empty and scrub weekly

• Overhead water tanks  keep tightly covered

• Coolers and air conditioner drainage trays  drain and clean weekly

• Discarded tyres, bottles, and containers  remove from the premises

• Construction site water collection points  report to local civic authorities

Removing standing water around the home and staying inside when mosquitoes are active significantly reduces exposure risk.

Personal Protection What Actually Works

Mosquito repellents: DEET-based repellents (20–30% concentration) applied to exposed skin provide the strongest protection against Aedes bites. Picaridin and oil of lemon eucalyptus-based repellents are effective alternatives. Reapply every 4 to 6 hours during outdoor activity.

Clothing: Wear full-sleeved, loose, light-coloured clothing  particularly during early morning and late afternoon when Aedes biting activity peaks. Light colours are preferred because dark clothing retains heat and attracts mosquitoes.

Mosquito nets and screens: Even during daytime, window screens and room nets prevent Aedes entry. For infants and young children who sleep or rest during the day, nets provide critical daytime protection.

Mosquito coils and vaporisers: Indoor insecticide vaporisers provide useful protection within closed rooms, particularly during the early morning hours when Aedes activity is highest.

Community-Level Action

Individual protection is necessary but insufficient in a high-density urban environment like Noida or Greater Noida. Community action  reporting waterlogging to municipal authorities, participating in fogging campaigns, and ensuring construction sites maintain breeding prevention  is essential for suppressing Aedes populations at scale.

When to Seek Immediate Medical Attention: Complications

Most chikungunya episodes are self-limiting and manageable at home with paracetamol, hydration, and rest. However, certain clinical situations require prompt evaluation at Felix Hospital.

Serious Complications of Chikungunya

CHIKV infection can occasionally be fatal, with neurological disease a particularly severe manifestation.

The acute phase can be followed by a chronic phase characterised by severe and persistent joint pain with occasional ophthalmic, neurological, and cardiac complications.

• Neurological complications: Encephalitis  inflammation of the brain  is a rare but serious complication seen primarily in neonates, the elderly, and immunocompromised patients. Signs include altered consciousness, seizures, or confusion alongside fever and rash.

• Cardiovascular complications: Myocarditis and cardiac arrhythmias have been reported in severe chikungunya, particularly in older patients with underlying heart disease.

• Neonatal chikungunya: Chikungunya can be debilitating and even deadly for newborns. Neonatal cases can be associated with encephalitis. Vertical transmission during delivery  a mother viraemic at the time of birth  is a recognised risk. Any newborn born to a mother with active chikungunya requires close neonatal monitoring.

• High-risk groups requiring lower threshold for hospitalisation: While chikungunya can affect people of all ages, older adults particularly those over 65, infants and young children, pregnant women, and people with high blood pressure, diabetes, heart disease, or other health conditions are more likely to experience severe symptoms or recover more slowly.

Come to Felix Hospital or call +91 9667064100 immediately if:

• Fever lasts beyond 7 days without improvement

• Joint pain is completely disabling  unable to walk, grip, or perform basic function

• Any neurological symptoms  confusion, seizure, altered consciousness

• Difficulty breathing or chest pain alongside fever

• Bleeding from any site  possible dengue co-infection

• Neonates with fever during or after maternal chikungunya

• Elderly patients with worsening confusion during monsoon fever season

• Joint pain persists beyond 12 weeks  requiring rheumatology assessment

Conclusion

Chikungunya is a disease that reveals its full character only over time. The fever announces it. The joint pain defines it. And for too many patients  up to half  chronic arthritis extends it long past the acute illness into weeks, months, or years of painful daily limitation.

The good news is that chikungunya is manageable at every stage  with the right diagnosis, the right medications, and the right rehabilitation. Chronic chikungunya arthritis, even when it has persisted for months, responds to structured anti-inflammatory therapy and physiotherapy. It is treatable. It is not something patients simply have to live with.

At Felix Hospital, Sector 137, Noida, our internal medicine, infectious disease, and rheumatology teams offer comprehensive chikungunya management  from same-day blood testing during the acute phase to specialist assessment and treatment of chronic chikungunya arthritis in patients whose joint pain has outlasted the fever.

If you or a family member is experiencing joint pain, fever, or rash during the monsoon season or if you are months post-chikungunya and still struggling with your joints  call +91 9667064100. You do not have to "wait it out." Evidence-based care exists, and it makes a real difference.